Italy Peptide Receptor Radionuclide Therapy (PRRT) Market, By Drug Type (Lutetium (Lu-177)-based, and Yttrium (Y-90)-based), By Indication (Gastroenteropancreatic Neuroendocrine Tumor, Foregut Neuroendocrine Tumor, Midgut Neuroendocrine Tumor, and Hindgut Neuroendocrine Tumor), By Distribution Channel (Hospital Pharmacies and Retail Pharmacies)
Select a License Type that Suits your Business Needs
US$ 2,200
Two thousand two hundred dollars
Single User License
( Full Report )
US$ 4,500
Four thousand five hundred dollars
Frequently purchased
Multi User License
( Full Report )
US$ 7,000
Seven thousand dollars
Corporate User License
( Full Report )
US$ 10000
Ten thousand dollars
Client Testimonials
Client Testimonials
Our Clients
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

860519526
9001:2015
27001:2022